IDR 96.0
(9.2%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 17.48 Billion | 24.16 Billion | 20.23 Billion | 17.15 Billion | 27.71 Billion | 18.31 Billion |
Net Income | -3.34 Billion | -10.91 Billion | 2.5 Billion | -4.99 Million | 3.07 Billion | 3.06 Billion |
Depreciation & Amortization | 20.61 Billion | 18.92 Billion | 18.8 Billion | 18.68 Billion | 19.14 Billion | 19.18 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 215.3 Million | 53.99 Billion | 36.53 Billion | 35.84 Billion | 43.77 Billion | 34.44 Billion |
Investing Cash Flow | 505.56 Million | 1.36 Billion | -2.99 Billion | -178.25 Million | 2.52 Billion | -575.36 Million |
Investments in PPE | -284.01 Million | -81.53 Million | -6.7 Million | -303.75 Million | -118.15 Million | -1.33 Billion |
Acquisitions | 70 Million | -1.44 Billion | - | 165.5 Million | 2.64 Billion | 143 Million |
Investment purchases | -862.17 Million | -1.58 Billion | -2.98 Billion | - | - | -762.27 Million |
Sales/Maturities of investments | 1.58 Billion | 3.02 Billion | - | - | - | 619.27 Million |
Other Investing Activities | 789.58 Million | 1.44 Billion | -2.98 Billion | -40 Million | 2.64 Billion | 762.27 Million |
Financing Cash Flow | -17.81 Billion | -24.12 Billion | -14.14 Billion | -12.67 Billion | -32.3 Billion | -17.75 Billion |
Debt repayment | -17.81 Billion | -1.37 Billion | -4.53 Billion | -12.4 Billion | -32.3 Billion | -17.75 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -15.92 Billion | -22.31 Billion | -18.3 Billion | -12.67 Billion | -32.3 Billion | 22 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 5.87 Billion | 4.46 Billion | 7.33 Billion | 3.06 Billion | 5.11 Billion | -838.97 Million |
Cash at end of period | 6.03 Billion | 5.87 Billion | 4.46 Billion | 7.33 Billion | 3.06 Billion | 5.11 Billion |
Capital Expenditure | -284.01 Million | -81.53 Million | -6.7 Million | -303.75 Million | -118.15 Million | -1.33 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 167.71 Million | 1.4 Billion | -2.86 Billion | 4.27 Billion | -2.04 Billion | 5.95 Billion |
Free Cash Flow | 17.19 Billion | 24.08 Billion | 20.22 Billion | 16.84 Billion | 27.59 Billion | 16.98 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.62 Billion | 269.28 Million | -1.91 Billion | -2.22 Billion | -3.34 Billion | -3.28 Billion |
Depreciation & Amortization | 5.04 Billion | 5.04 Billion | 5.07 Billion | 6.42 Billion | 20.59 Billion | 4.72 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 1.79 Billion | -1.09 Billion | 6.91 Billion | 12.85 Billion | 41.42 Billion | 12.64 Billion |
Investing Cash Flow | -8.24 Million | - | -1.18 Billion | 58.77 Million | 505.56 Million | -175 Million |
Investments in PPE | -54.63 Million | - | -663 Million | - | -284.01 Million | -175 Million |
Acquisitions | 46.39 Million | - | 68 Million | 70 Million | 70 Million | - |
Investment purchases | - | - | -593.5 Million | -11.22 Million | -862.17 Million | - |
Sales/Maturities of investments | - | - | - | - | 1.58 Billion | - |
Other Investing Activities | - | - | -525.5 Million | 58.77 Million | 789.58 Million | - |
Financing Cash Flow | -10.71 Billion | -4.09 Billion | -1.52 Billion | -3.77 Billion | -17.81 Billion | -4.17 Billion |
Debt repayment | -10.58 Billion | -4.09 Billion | -1.38 Billion | -12.73 Billion | -1.3 Billion | -4.17 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -135 Million | -135 Million | - | -15.92 Billion | -15.92 Billion | -4.17 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 3.38 Billion | 3.25 Billion | 6.03 Billion | 5.55 Billion | 5.87 Billion | 5.25 Billion |
Cash at end of period | 2.12 Billion | 3.38 Billion | 3.25 Billion | 6.03 Billion | 6.03 Billion | 5.55 Billion |
Capital Expenditure | -54.63 Million | - | -663 Million | - | -284.01 Million | -175 Million |
Effect of forex changes on cash | - | - | - | 1.00 | - | -1.00 |
Net cash flow / Change in cash | -1.26 Billion | 129.43 Million | -2.78 Billion | 487.39 Million | 167.71 Million | 292.49 Million |
Free Cash Flow | 9.41 Billion | 4.22 Billion | -735.36 Million | 4.2 Billion | 17.19 Billion | 4.46 Billion |
AMPY
BIOAF
XOM
GANGAFORGE
JIHD
9271